Instructions

    Take Another Course

Post-Test

For people with type 2 diabetes, alpha-glucosidase inhibitors work in the intestine to reduce glucose absorption.

Alpha-glucosidase inhibitors slow the digestion of carbohydrates in the small intestine. These medications work by inhibiting enzymes in the intestine that break down carbohydrates, so glucose levels rise more slowly after eating. Prescribed brands are Precose (acarbose) and Glyset (miglitol).

Some people who take these medications experience intestinal gas, bloating, and diarrhea. However, these side effects often diminish with continued use or dosage adjustment.

Newer Medications:

SGLT-2 Inhibitors

Suppresses an enzyme that facilitates glucose transport across renal tubules

Lowers “renal threshhold” for urinary glucose excretion

Facilitates weight loss, reduction in glycemia

Does not cause hypoglycemia

Once daily oral medication

 

Brand name

Generic name

 

Invokanna

canagliflozin

 

Farxiga

dapaglifolozin

DPP-4 Inhibitors  

Among the newest diabetes medications are DPP-IV (4) inhibitors. They may be the perfect example of a “domino effect” in diabetes treatment. Let’s take a moment to examine how this class of drugs works. 

When food passes through the stomach and enters the small intestine, specific cells of the intestine produce a substance called Glucagon-Like-Peptide-1(GLP-1).  Once in the circulation, GLP-1 does a number of things: 

It makes it easier for the pancreas to release its stored-up insulin, but only in the presence of elevated blood sugar (so it does not cause hypoglycemia)

It decreases glucagon secretion from the pancreas (glucagon is a hormone that raises blood sugar)

It promotes the growth and duplication of cells in the pancreas that produce insulin

It slows the movement of food from the stomach into the intestines, and

It decreases appetite.

So GLP-1 is very good for helping to control blood sugar levels. Unfortunately, GLP-1 only lasts for a few minutes because it is broken down by an enzyme called DPP-IV. DPP-IV inhibitors are designed to counter this action and keep DPP-IV from breaking down GLP-1, allowing GLP-1 to circulate longer and work harder.

 

Click on the link at left to go to your desired page: 

Page 1  Page 2  Page 3  Page 4  Page 5  Page 6  Page 7  Page 8  Page 9  Page 10  Page 11  Page 12  Page 13  Page 14  Page 15  Page 16  Page 17  Page 18  Page 19  Page 20  Page 21  Page 22  Page 23  Post-Test

Continue
2020 Hi-R-Ed Online University. All courses posted on this site are the property of Hi-R-Ed Online University unless otherwise stated. Courses may not be copied or transferred in electronic, printed, or other forms, or modified for any purpose without explicit written consent of Hi-R-Ed Online University.